OBJECTIVE: Polycythemia vera (PV) is a myeloproliferative disorder, arising from the acquired mutation(s) of a hematopoietic stem cell. The JAK2 V617F somatic mutation is found in most PV patients; however, it is not the disease-initiating mutation. Because microRNAs (miRNAs) play a regulatory role in hematopoiesis, we studied miRNA expressions in PV and normal erythropoiesis. METHODS: Peripheral blood mononuclear cells were cultured in a three-phase liquid system resulting in synchronized expansion of erythroid progenitors. Using gene-expression profiling by CombiMatrix MicroRNArray, we searched for PV-specific changes at days 1, 14, and 21. Twelve miRNA candidates were then reevaluated by quantitative real-time polymerase chain reaction in a larger number of samples obtained from progenitors at the same stage of differentiation. RESULTS: A significant difference in miR-150 expression was found in PV. In normal erythropoiesis, three expression patterns of miRNAs were observed: progressive downregulation of miR-150, miR-155, miR-221, miR-222; upregulation of miR-451, miR-16 at late stages of erythropoiesis; and biphasic regulation of miR-339, miR-378. The miR-451 appears to be erythroid-specific. CONCLUSIONS: We identified the miRNAs with regulated expression in erythropoiesis; one appeared to be PV-specific. Their miRNA expression levels define early, intermediate, and late stages of erythroid differentiation. The validity of our findings was confirmed in nonexpanded peripheral blood cells.
OBJECTIVE:Polycythemia vera (PV) is a myeloproliferative disorder, arising from the acquired mutation(s) of a hematopoietic stem cell. The JAK2 V617F somatic mutation is found in most PV patients; however, it is not the disease-initiating mutation. Because microRNAs (miRNAs) play a regulatory role in hematopoiesis, we studied miRNA expressions in PV and normal erythropoiesis. METHODS: Peripheral blood mononuclear cells were cultured in a three-phase liquid system resulting in synchronized expansion of erythroid progenitors. Using gene-expression profiling by CombiMatrix MicroRNArray, we searched for PV-specific changes at days 1, 14, and 21. Twelve miRNA candidates were then reevaluated by quantitative real-time polymerase chain reaction in a larger number of samples obtained from progenitors at the same stage of differentiation. RESULTS: A significant difference in miR-150 expression was found in PV. In normal erythropoiesis, three expression patterns of miRNAs were observed: progressive downregulation of miR-150, miR-155, miR-221, miR-222; upregulation of miR-451, miR-16 at late stages of erythropoiesis; and biphasic regulation of miR-339, miR-378. The miR-451 appears to be erythroid-specific. CONCLUSIONS: We identified the miRNAs with regulated expression in erythropoiesis; one appeared to be PV-specific. Their miRNA expression levels define early, intermediate, and late stages of erythroid differentiation. The validity of our findings was confirmed in nonexpanded peripheral blood cells.
Authors: Shakti H Ramkissoon; Lori A Mainwaring; Yoji Ogasawara; Keyvan Keyvanfar; J Philip McCoy; Elaine M Sloand; Sachiko Kajigaya; Neal S Young Journal: Leuk Res Date: 2005-10-12 Impact factor: 3.156
Authors: Nadia Felli; Laura Fontana; Elvira Pelosi; Rosanna Botta; Desirée Bonci; Francesco Facchiano; Francesca Liuzzi; Valentina Lulli; Ornella Morsilli; Simona Santoro; Mauro Valtieri; George Adrian Calin; Chang-Gong Liu; Antonio Sorrentino; Carlo M Croce; Cesare Peschle Journal: Proc Natl Acad Sci U S A Date: 2005-12-05 Impact factor: 11.205
Authors: Ramiro Garzon; Flavia Pichiorri; Tiziana Palumbo; Rodolfo Iuliano; Amelia Cimmino; Rami Aqeilan; Stefano Volinia; Darshna Bhatt; Hansjuerg Alder; Guido Marcucci; George A Calin; Chang-Gong Liu; Clara D Bloomfield; Michael Andreeff; Carlo M Croce Journal: Proc Natl Acad Sci U S A Date: 2006-03-20 Impact factor: 11.205
Authors: Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce Journal: Cancer Res Date: 2005-08-15 Impact factor: 12.701
Authors: Duonan Yu; Camila O dos Santos; Guowei Zhao; Jing Jiang; Julio D Amigo; Eugene Khandros; Louis C Dore; Yu Yao; Janine D'Souza; Zhe Zhang; Saghi Ghaffari; John Choi; Sherree Friend; Wei Tong; Jordan S Orange; Barry H Paw; Mitchell J Weiss Journal: Genes Dev Date: 2010-08-01 Impact factor: 11.361
Authors: John R Finnerty; Wang-Xia Wang; Sébastien S Hébert; Bernard R Wilfred; Guogen Mao; Peter T Nelson Journal: J Mol Biol Date: 2010-08-01 Impact factor: 5.469
Authors: Louis C Dore; Julio D Amigo; Camila O Dos Santos; Zhe Zhang; Xiaowu Gai; John W Tobias; Duonan Yu; Alyssa M Klein; Christine Dorman; Weisheng Wu; Ross C Hardison; Barry H Paw; Mitchell J Weiss Journal: Proc Natl Acad Sci U S A Date: 2008-02-26 Impact factor: 11.205
Authors: Srikanth Nagalla; Chad Shaw; Xianguo Kong; Altaf A Kondkar; Leonard C Edelstein; Lin Ma; Junmei Chen; G Stanley McKnight; José A López; Linghai Yang; Ying Jin; Molly S Bray; Suzanne M Leal; Jing-Fei Dong; Paul F Bray Journal: Blood Date: 2011-03-17 Impact factor: 22.113
Authors: Michael J Parsons; Christina H Grimm; Jose L Paya-Cano; Karen Sugden; Wilfried Nietfeld; Hans Lehrach; Leonard C Schalkwyk Journal: Mamm Genome Date: 2008-07-02 Impact factor: 2.957